EW
愛德華生命科學 Edwards Lifesciences Corp
-0.54 (-0.60%)88.74USD981K成交股數51.1B市值53.8本益比(近四季)7.7股價營收比+13.6%營收年增(近四季)2026-10-29下次財報
內部人交易 SEC Form 4 · 董事、高階主管與持股 10% 以上股東 · 交易後兩個營業日內申報
買賣點與股價近一年
● 公開市場買進 · ● 公開市場賣出 · 空心 = 10b5-1 預設計畫(事先排程,不代表當下看法)。近一年,只畫 P / S 兩種代碼。
統計
| 近 90 天 買進筆數 · 金額 · 人數 | 0 · 0.00 · 0 |
|---|---|
| 近 90 天 賣出筆數 · 金額 · 人數 | 12 · 4.6M · 6 |
| 其中 10b5-1 計畫賣出 | 4 筆 |
| 近 180 天 買進 · 賣出金額 | 0.00 · 14.3M |
| 近 180 天 淨額 | −14.3M |
公開市場買進(P)是內部人自掏腰包,通常比賣出更有資訊含量 —— 賣出的理由很多(繳稅、分散、買房),買進的理由只有一個。
10b5-1 是事先排定的交易計畫,執行時點不反映當下看法。獲配股票(A)、繳稅扣股(F)、選擇權執行(M)是薪酬流程,不是意見。
| 交易日 | 申報日 | 申報人 | 職稱 | 代碼 | 股數 | 價格 | 金額 | 交易後持股 | 原件 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 | 09-14 | Markowitz Wayne | CVP, JAPAC | F 繳稅扣股 | 568 | 84.37 | 48K | 19.4K | SEC |
| 2026-09-13 | 09-14 | Dahl Andrew M. | SVP, Corporate Controller | F 繳稅扣股 | 253 | 84.37 | 21K | 14.6K | SEC |
| 2026-09-11 | 09-14 | Markowitz Wayne | CVP, JAPAC | F 繳稅扣股 | 355 | 86.77 | 31K | 19.9K | SEC |
| 2026-09-11 | 09-11 | Chopra Daveen | CVP, TMTT, Surgical & IHFM | F 繳稅扣股 | 398 | 86.77 | 35K | 43.9K | SEC |
| 2026-09-11 | 09-11 | Lippis Daniel J. | CVP, TAVR | S 公開市場賣出(10b5-1) | 619 | 87.51 | 54K | 40.0K | SEC |
| 2026-09-11 | 09-11 | Lippis Daniel J. | CVP, TAVR | M 選擇權執行 | 619 | 72.68 | 45K | 40.7K | SEC |
| 2026-08-31 | 08-31 | Dahl Andrew M. | SVP, Corporate Controller | S 公開市場賣出 | 544 | 91.06 | 50K | 14.9K | SEC |
| 2026-08-28 | 08-28 | Bruls Annette | CVP, EMEACLA | S 公開市場賣出 | 2.6K | 89.98 | 238K | 18.0K | SEC |
| 2026-08-26 | 08-26 | Chopra Daveen | CVP, TMTT, Surgical & IHFM | M 選擇權執行 | 31.8K | 72.68 | 2.3M | 76.1K | SEC |
| 2026-08-26 | 08-26 | Markowitz Wayne | CVP, JAPAC | S 公開市場賣出 | 1.2K | 91.47 | 113K | 20.3K | SEC |
| 2026-08-26 | 08-26 | Chopra Daveen | CVP, TMTT, Surgical & IHFM | S 公開市場賣出 | 30.6K | 90.99 | 2.8M | 44.3K | SEC |
| 2026-08-26 | 08-26 | Chopra Daveen | CVP, TMTT, Surgical & IHFM | S 公開市場賣出 | 1.2K | 91.76 | 106K | 75.0K | SEC |
| 2026-08-11 | 08-11 | Lippis Daniel J. | CVP, TAVR | M 選擇權執行 | 619 | 72.68 | 45K | 40.7K | SEC |
| 2026-08-11 | 08-11 | Lippis Daniel J. | CVP, TAVR | S 公開市場賣出(10b5-1) | 619 | 92.03 | 57K | 40.0K | SEC |
| 2026-07-30 | 07-30 | Markowitz Wayne | CVP, JAPAC | S 公開市場賣出 | 146 | 86.03 | 13K | 21.5K | SEC |
| 2026-07-28 | 07-28 | Markowitz Wayne | CVP, JAPAC | S 公開市場賣出 | 9.6K | 85.06 | 819K | 21.7K | SEC |
| 2026-07-28 | 07-28 | Markowitz Wayne | CVP, JAPAC | M 選擇權執行 | 9.6K | 74.02 | 713K | 31.3K | SEC |
| 2026-07-27 | 07-27 | Zovighian Bernard J | CEO | S 公開市場賣出 | 2.9K | 83.93 | 245K | 8.9K | SEC |
| 2026-07-27 | 07-27 | Zovighian Bernard J | CEO | G 贈與 | 320 | – | – | 98.8K | SEC |
| 2026-07-27 | 07-27 | Zovighian Bernard J | CEO | G 贈與 | 320 | – | – | 11.8K | SEC |
| 2026-07-11 | 07-13 | Bruls Annette | CVP, EMEACLA | F 繳稅扣股 | 109 | 92.21 | 10K | 20.6K | SEC |
| 2026-07-10 | 07-10 | Lippis Daniel J. | CVP, TAVR | M 選擇權執行 | 619 | 72.68 | 45K | 40.7K | SEC |
| 2026-07-10 | 07-10 | Lippis Daniel J. | CVP, TAVR | S 公開市場賣出(10b5-1) | 619 | 91.70 | 57K | 40.0K | SEC |
| 2026-07-09 | 07-10 | Mistras Theodora | CVP, Chief Financial Officer | A 獲配股票 | 12.3K | – | – | 99.9K | SEC |
| 2026-07-09 | 07-10 | Mistras Theodora | CVP, Chief Financial Officer | A 獲配股票 | 87.6K | – | – | 87.6K | SEC |
| 2026-07-07 | 07-07 | Lippis Daniel J. | CVP, TAVR | F 繳稅扣股 | 377 | 95.18 | 36K | 40.0K | SEC |
| 2026-06-30 | 06-30 | Lippis Daniel J. | CVP, TAVR | M 選擇權執行 | 619 | 72.68 | 45K | 41.0K | SEC |
| 2026-06-30 | 06-30 | Lippis Daniel J. | CVP, TAVR | S 公開市場賣出(10b5-1) | 619 | 91.40 | 57K | 40.4K | SEC |
| 2026-06-17 | 06-17 | Zovighian Bernard J | CEO | S 公開市場賣出(10b5-1) | 523 | 87.92 | 46K | 11.5K | SEC |
| 2026-05-29 | 05-29 | Dahl Andrew M. | SVP, Corporate Controller | S 公開市場賣出 | 568 | 86.08 | 49K | 15.3K | SEC |
| 2026-05-27 | 05-27 | BOBO DONALD E JR | CVP,Strategy/Corp Development | S 公開市場賣出 | 23.1K | 86.42 | 2.0M | 98.6K | SEC |
| 2026-05-22 | 05-22 | Chopra Daveen | CVP, TMTT & Surgical | S 公開市場賣出 | 1.5K | 84.60 | 127K | 44.3K | SEC |
| 2026-05-18 | 05-18 | Lippis Daniel J. | CVP, TAVR | M 選擇權執行 | 620 | 72.68 | 45K | 41.0K | SEC |
| 2026-05-18 | 05-18 | Lippis Daniel J. | CVP, TAVR | S 公開市場賣出(10b5-1) | 620 | 81.14 | 50K | 40.4K | SEC |
| 2026-05-15 | 05-18 | BOBO DONALD E JR | CVP,Strategy/Corp Development | S 公開市場賣出 | 8.0K | 81.82 | 655K | 31.0K | SEC |
| 2026-05-15 | 05-18 | BOBO DONALD E JR | CVP,Strategy/Corp Development | S 公開市場賣出 | 10.0K | 82.07 | 818K | 22.8K | SEC |
| 2026-05-12 | 05-12 | Zovighian Bernard J | CEO | G 贈與 | 26.6K | – | – | 48.4K | SEC |
| 2026-05-12 | 05-12 | Zovighian Bernard J | CEO | S 公開市場賣出(10b5-1) | 845 | 78.40 | 66K | 47.5K | SEC |
| 2026-05-12 | 05-12 | Zovighian Bernard J | CEO | G 贈與 | 26.6K | – | – | 99.2K | SEC |
| 2026-05-12 | 05-12 | Zovighian Bernard J | CEO | S 公開市場賣出(10b5-1) | 35.5K | 77.92 | 2.8M | 12.0K | SEC |
| 2026-05-11 | 05-12 | BOBO DONALD E JR | CVP,Strategy/Corp Development | F 繳稅扣股 | 7.5K | 79.96 | 597K | 32.8K | SEC |
| 2026-05-11 | 05-12 | Zovighian Bernard J | CEO | F 繳稅扣股 | 26.2K | 79.96 | 2.1M | 126K | SEC |
| 2026-05-11 | 05-12 | Zovighian Bernard J | CEO | M 選擇權執行 | 47.2K | – | – | 157K | SEC |
| 2026-05-11 | 05-12 | Chopra Daveen | CVP, TMTT & Surgical | F 繳稅扣股 | 7.5K | 79.96 | 603K | 45.8K | SEC |
| 2026-05-11 | 05-12 | BOBO DONALD E JR | CVP,Strategy/Corp Development | M 選擇權執行 | 13.5K | – | – | 40.2K | SEC |
| 2026-05-11 | 05-12 | Chopra Daveen | CVP, TMTT & Surgical | M 選擇權執行 | 13.6K | – | – | 53.4K | SEC |
| 2026-05-11 | 05-11 | Ullem Scott B. | CVP, Chief Financial Officer | F 繳稅扣股 | 11.0K | 79.96 | 880K | 46.7K | SEC |
| 2026-05-11 | 05-11 | Markowitz Wayne | CVP, JAPAC | S 公開市場賣出 | 593 | 79.73 | 47K | 21.7K | SEC |
| 2026-05-11 | 05-11 | Ullem Scott B. | CVP, Chief Financial Officer | M 選擇權執行 | 19.8K | – | – | 57.7K | SEC |
| 2026-05-11 | 05-11 | Zovighian Bernard J | CEO | G 贈與 | 5.5K | – | – | 21.8K | SEC |
| 2026-05-11 | 05-11 | Zovighian Bernard J | CEO | G 贈與 | 5.5K | – | – | 105K | SEC |
| 2026-05-11 | 05-11 | Lippis Daniel J. | CVP, TAVR | F 繳稅扣股 | 362 | 79.96 | 29K | 40.4K | SEC |
| 2026-05-08 | 05-11 | Markowitz Wayne | CVP, JAPAC | F 繳稅扣股 | 226 | 82.76 | 19K | 22.3K | SEC |
| 2026-05-08 | 05-11 | Zovighian Bernard J | CEO | G 贈與 | 4.2K | – | – | 16.3K | SEC |
| 2026-05-08 | 05-11 | Zovighian Bernard J | CEO | G 贈與 | 4.2K | – | – | 116K | SEC |
| 2026-05-08 | 05-11 | Zovighian Bernard J | CEO | F 繳稅扣股 | 5.4K | 82.76 | 447K | 110K | SEC |
| 2026-05-08 | 05-08 | Bruls Annette | CVP, EMEACLA | F 繳稅扣股 | 84 | 82.76 | 7K | 20.7K | SEC |
| 2026-05-08 | 05-08 | Ullem Scott B. | CVP, Chief Financial Officer | F 繳稅扣股 | 1.7K | 82.76 | 137K | 37.9K | SEC |
| 2026-05-08 | 05-08 | GALLAHUE KIERAN | Director | A 獲配股票 | 1.1K | – | – | 4.3K | SEC |
| 2026-05-08 | 05-08 | Feinberg David T | Director | A 獲配股票 | 3.3K | – | – | 9.1K | SEC |
| 2026-05-08 | 05-08 | BOBO DONALD E JR | CVP,Strategy/Corp Development | F 繳稅扣股 | 1.0K | 82.76 | 86K | 26.8K | SEC |
| 2026-05-08 | 05-08 | Sequeira Ramona | Director | A 獲配股票 | 3.3K | – | – | 6.8K | SEC |
| 2026-05-08 | 05-08 | Davis Leslie C. | Director | A 獲配股票 | 3.3K | – | – | 9.8K | SEC |
| 2026-05-08 | 05-08 | LORANGER STEVEN R | Director | A 獲配股票 | 1.1K | – | – | 9.0K | SEC |
| 2026-05-08 | 05-08 | VALERIANI NICHOLAS J | Director | A 獲配股票 | 5.1K | – | – | 84.4K | SEC |
| 2026-05-08 | 05-08 | Lippis Daniel J. | CVP, TAVR | F 繳稅扣股 | 450 | 82.76 | 37K | 40.8K | SEC |
| 2026-05-08 | 05-08 | STONE HEISZ LESLIE | Director | A 獲配股票 | 3.3K | – | – | 34.2K | SEC |
| 2026-05-08 | 05-08 | Dahl Andrew M. | SVP, Corporate Controller | F 繳稅扣股 | 289 | 82.76 | 24K | 15.9K | SEC |
| 2026-05-08 | 05-08 | LAVIOLETTE PAUL A | Director | A 獲配股票 | 3.3K | – | – | 17.6K | SEC |
| 2026-05-08 | 05-08 | Chopra Daveen | CVP, TMTT & Surgical | F 繳稅扣股 | 1.1K | 82.76 | 94K | 39.8K | SEC |
| 2026-05-08 | 05-08 | LORANGER STEVEN R | Director | A 獲配股票 | 3.3K | – | – | 7.9K | SEC |
| 2026-05-08 | 05-08 | GALLAHUE KIERAN | Director | A 獲配股票 | 3.3K | – | – | 3.3K | SEC |
| 2026-05-07 | 05-11 | Markowitz Wayne | CVP, JAPAC | F 繳稅扣股 | 264 | 83.20 | 22K | 22.5K | SEC |
| 2026-05-07 | 05-11 | Zovighian Bernard J | CEO | F 繳稅扣股 | 4.2K | 83.20 | 346K | 120K | SEC |
| 2026-05-07 | 05-11 | Zovighian Bernard J | CEO | A 獲配股票 | 43.8K | – | – | 124K | SEC |
| 2026-05-07 | 05-11 | Markowitz Wayne | CVP, JAPAC | A 獲配股票 | 5.2K | – | – | 22.8K | SEC |
| 2026-05-07 | 05-08 | Chopra Daveen | CVP, TMTT & Surgical | A 獲配股票 | 9.7K | – | – | 41.6K | SEC |
| 2026-05-07 | 05-08 | BOBO DONALD E JR | CVP,Strategy/Corp Development | F 繳稅扣股 | 831 | 83.20 | 69K | 27.8K | SEC |
| 2026-05-07 | 05-08 | BOBO DONALD E JR | CVP,Strategy/Corp Development | A 獲配股票 | 7.8K | – | – | 28.6K | SEC |
| 2026-05-07 | 05-08 | Ullem Scott B. | CVP, Chief Financial Officer | F 繳稅扣股 | 1.4K | 83.20 | 114K | 39.6K | SEC |
機構持股(13F) 管理規模 1 億美元以上的機構,每季末後 45 天內申報 · 最新 2026-06-30
前 25 大持有機構季末市值 · 與前一季股數比較
| 機構 | 持股 | 季末市值 | 股數季變化 | 動作 |
|---|---|---|---|---|
| BlackRock, Inc. | 58.8M | 5.3B | 新進 | 新進 |
| VANGUARD CAPITAL MANAGEMENT LLC | 37.6M | 3.4B | 新進 | 新進 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 26.4M | 2.4B | 新進 | 新進 |
| STATE STREET CORP | 26.3M | 2.4B | 新進 | 新進 |
| JPMORGAN CHASE & CO | 22.8M | 2.1B | 新進 | 新進 |
| WELLINGTON MANAGEMENT GROUP LLP | 16.8M | 1.5B | 新進 | 新進 |
| GEODE CAPITAL MANAGEMENT, LLC | 15.4M | 1.4B | 新進 | 新進 |
| Bank of New York Mellon Corp | 14.1M | 1.3B | 新進 | 新進 |
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | 13.0M | 1.2B | 新進 | 新進 |
| Ninety One UK Ltd | 12.3M | 1.1B | 新進 | 新進 |
| Aristotle Capital Management, LLC | 8.7M | 784M | 新進 | 新進 |
| FMR LLC | 8.4M | 763M | 新進 | 新進 |
| 挪威主權基金 NORGES BANK | 8.4M | 757M | 新進 | 新進 |
| ALLIANCEBERNSTEIN L.P. | 8.7M | 694M | 新進 | 新進 |
| BROWN ADVISORY INC | 7.4M | 666M | 新進 | 新進 |
| BANK OF AMERICA CORP /DE/ | 6.7M | 605M | 新進 | 新進 |
| Artisan Partners Limited Partnership | 6.6M | 599M | 新進 | 新進 |
| MORGAN STANLEY | 6.3M | 573M | 新進 | 新進 |
| DEUTSCHE BANK AG\ | 5.7M | 517M | 新進 | 新進 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 5.7M | 514M | 新進 | 新進 |
| NORTHERN TRUST CORP | 5.7M | 513M | 新進 | 新進 |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 5.5M | 497M | 新進 | 新進 |
| WELLCOME TRUST LTD (THE) as trustee of the WELLCOME TRUST | 4.8M | 434M | 新進 | 新進 |
| GOLDMAN SACHS GROUP INC | 4.5M | 412M | 新進 | 新進 |
| Legal & General Group Plc | 4.3M | 389M | 新進 | 新進 |
持有機構數近 12 季
每季 13F 申報中持有本股的機構家數;綠柱 = 比上季少。機構數是「有多少人在船上」,不是「買了多少」。
| 持有機構 · 季變化 | 1,330 +40 |
|---|---|
| 新進 / 出清 / 加碼 / 減碼 | 1330 / 0 / 0 / 0 |
| 機構合計持股 · 佔流通股 | 524M · 91.0% |
| 合計季末市值 | 46.2B |
13F 只申報多頭部位(含可轉債與選擇權,選擇權這裡已排除),不申報放空,也不申報 1 億美元以下的機構。同一集團多個申報主體會各算一家。
放空餘額 FINRA 每月兩次(15 日與月底結算)· 最新 2026-08-31
空單佔流通股近 13 個月
FINRA 每月兩次結算的空單餘額佔流通股數的比例,近 13 個月。滑到柱子看股數與回補天數。
最新一期
| 空單股數 | 9.0M |
|---|---|
| 與上期比 | -11.9% |
| 佔流通股數 | 1.57% |
| 日均成交量 | 2.8M |
| 回補天數 | 3.2 天 |
空單佔比 10% 以上算高、20% 以上算很高(這是通行的說法,不是本站的判斷)。回補天數 = 空單 ÷ 日均量,天數愈長,空方要出場時愈容易推升股價。
放空餘額是「有人借股票賣掉還沒還」的存量,不代表看空的人正在加碼;避險基金做多空配對時也會產生空單。
| 結算日 | 空單股數 | 與上期比 | 佔流通股 | 日均量 | 回補天數 |
|---|---|---|---|---|---|
| 2026-08-31 | 9.0M | -11.9% | 1.57% | 2.8M | 3.2 |
| 2026-08-14 | 10.2M | +2.0% | 1.78% | 3.3M | 3.1 |
| 2026-07-31 | 10.0M | -11.5% | 1.74% | 5.7M | 1.8 |
| 2026-07-15 | 11.4M | -1.0% | 1.97% | 4.5M | 2.5 |
| 2026-06-30 | 11.5M | -2.8% | 1.99% | 5.4M | 2.1 |
| 2026-06-15 | 11.8M | -3.0% | 2.05% | 4.9M | 2.4 |
| 2026-05-29 | 12.2M | +6.8% | 2.11% | 5.2M | 2.3 |
| 2026-05-15 | 11.4M | +8.1% | 1.98% | 4.5M | 2.5 |
| 2026-04-30 | 10.5M | +12.9% | 1.83% | 6.3M | 1.7 |
| 2026-04-15 | 9.3M | -6.4% | 1.62% | 4.7M | 2.0 |
| 2026-03-31 | 10.0M | -8.9% | 1.73% | 4.4M | 2.3 |
| 2026-03-13 | 10.9M | -11.6% | 1.90% | 5.1M | 2.2 |
| 2026-02-27 | 12.4M | +56.6% | 2.15% | 4.6M | 2.7 |
| 2026-02-13 | 7.9M | -2.4% | 1.37% | 6.2M | 1.3 |
| 2026-01-30 | 8.1M | +2.2% | 1.40% | 3.5M | 2.3 |
| 2026-01-15 | 7.9M | +10.9% | 1.37% | 3.9M | 2.1 |
| 2025-12-31 | 7.1M | +26.6% | 1.24% | 2.8M | 2.6 |
| 2025-12-15 | 5.6M | -19.2% | 0.98% | 3.0M | 1.9 |
| 2025-11-28 | 7.0M | -28.6% | 1.21% | 3.8M | 1.8 |
| 2025-11-14 | 9.8M | +7.2% | 1.70% | 3.7M | 2.6 |
| 2025-10-31 | 9.1M | +17.1% | 1.58% | 6.3M | 1.5 |
| 2025-10-15 | 7.8M | +4.4% | 1.35% | 4.1M | 1.9 |
| 2025-09-30 | 7.5M | +2.8% | 1.29% | 5.3M | 1.4 |
| 2025-09-15 | 7.3M | -29.9% | 1.26% | 3.6M | 2.0 |
| 2025-08-29 | 10.4M | +27.2% | 1.80% | 4.3M | 2.4 |
| 2025-08-15 | 8.1M | +1.7% | 1.41% | 3.3M | 2.5 |